مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

336
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

209
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

MANAGEMENT OF SUBCLINICAL HYPERTHYROIDISM

Pages

  490-496

Abstract

 The ideal approach for adequate management of subclinical HYPERTHYROIDISM (low levels of thyroid-stimulating hormone [TSH] and normal thyroid hormone level) is a matter of intense debate among endocrinologists. The prevalence of low serum TSH levels ranges between 0.5% in children and 15% in the elderly population. Mild subclinical HYPERTHYROIDISM is more common than severe subclinical HYPERTHYROIDISM. Transient suppression of TSH secretion may occur because of several reasons; thus, corroboration of results from different assessments is essential in such cases. During differential diagnosis of HYPERTHYROIDISM, pituitary or hypothalamic disease, euthyroid sick syndrome, and drug-mediated suppression of TSH must be ruled out. A low plasma TSH value is also typically seen in the first trimester of gestation. Factitial or iatrogenic TSH inhibition caused by excessive intake of levothyroxine should be excluded by checking the patient’s medication history. If these nonthyroidal causes are ruled out during differential diagnosis, either transient or long-term endogenous thyroid hormone excess, usually caused by GRAVES’ DISEASE or nodular goiter, should be considered as the cause of low circulating TSH levels. We recommend the following 6-step process for the assessment and treatment of this common hormonal disorder: (1) confirmation, (2) evaluation of severity, (3) investigation of the cause, (4) assessment of potential complications, (5) evaluation of the necessity of treatment, and (6) if necessary, selection of the most appropriate treatment. In conclusion, management of subclinical HYPERTHYROIDISM merits careful monitoring through regular assessment of thyroid function. Treatment is mandatory in older patients (>65 years) or in presence of comorbidities (such as osteoporosis and atrial fibrillation).

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    PALACIOS, SILVIA SANTOS, PASCUAL CORRALES, EIDER, & GALOFRE, JUAN CARLOS. (2012). MANAGEMENT OF SUBCLINICAL HYPERTHYROIDISM. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), 10(2), 490-496. SID. https://sid.ir/paper/297438/en

    Vancouver: Copy

    PALACIOS SILVIA SANTOS, PASCUAL CORRALES EIDER, GALOFRE JUAN CARLOS. MANAGEMENT OF SUBCLINICAL HYPERTHYROIDISM. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM)[Internet]. 2012;10(2):490-496. Available from: https://sid.ir/paper/297438/en

    IEEE: Copy

    SILVIA SANTOS PALACIOS, EIDER PASCUAL CORRALES, and JUAN CARLOS GALOFRE, “MANAGEMENT OF SUBCLINICAL HYPERTHYROIDISM,” INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM (IJEM), vol. 10, no. 2, pp. 490–496, 2012, [Online]. Available: https://sid.ir/paper/297438/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button